Bayer Raises Margin Forecasts Due to Strong Health Care Business...

Wenning: Health care is a growth engine. Bayer HealthCare (BHC) has raised its Ebitda margin forecast for 2007 from 24%, to 25%, and increased its Ebitda margin forecast for 2009 from 27%, to 28%. The company cites a quicker-than-expected integration of the former operations of Schering, which Bayer acquired last year; adoption of a new research strategy; and optimization of BHC’s pharmaceuticals pipeline. Bayer says it expects group Ebitda margins to increase from 19.3% in 2006, to more than 20% this year and more than 22% before 2009, as a result of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers